表达产肠毒素性大肠埃希菌STa-K99融合蛋白重组腺病毒的免疫学特性研究

为研究表达产肠毒素性大肠埃希菌(ETEC)耐热性肠毒素STa与粘附素K99融合蛋白重组腺病毒rAd.STa-K99的免疫学特性,本实验将rAd.STa-K99经肌肉注射免疫小鼠,采用ELISA法分别检测了特异性IgG、SIgA、脾脏淋巴细胞增殖活性水平及CD4+、CD8+T淋巴细胞分型比值;并通过攻毒保护试验对其免疫效果进行评价.结果表明,免疫后小鼠特异性IgG、SIgA及脾脏淋巴细胞增殖活性水平显著升高;CD4+/CD8+值显著增大;动物攻毒保护率达到70％.结果表明rAd.STa-K99可以刺激小鼠机体产生较高水平的体液免疫、特异性细胞免疫和肠道粘膜免疫反应,并对小鼠提供有效保护.本实验为研制预防由ETEC引起的新生动物腹泻重组腺病毒疫苗奠定了基础.     

中药“救必应”水提取物对产ESBLs大肠杆菌耐药性的影响

“救必应”为冬青科植物铁冬青的树皮或根皮水浸出物制备,具有广谱的抗菌作用.为研究中药“救必应”对产超广谱β-内酰胺酶(ESBLs)大肠杆菌耐药性的影响,本研究将产ESBLs的E.coli在亚抑菌浓度的中药“救必应”中传代,采用微量稀释法测定抗生素对产ESBLs的E.coli最小抑菌浓度(MIC),并通过透射电镜观察中药作用后细菌形态学变化.结果显示,中药“救必应”可以显著降低产ESBLs的E.coli对阿莫西林、加替沙星、诺氟沙星、盐酸左旋氧氟沙星、乙酰甲喹、磺胺间甲氧嘧啶钠、克林沙星、氟苯尼考的MIC值,并且MIC均降低4倍;此外,中药作用后可以引起细菌细胞壁的皱裂、干瘪、折叠、缩短等形态变化.     

新疆不同地区牛源大肠杆菌耐药性分析

This study was aimed to investigate the resistance of Escherichia coli isolates from cattle farms in Xinjiang to antibiotics. The resistances of Escherichia coli isolates from cattle farms in five regions to commonly used antibiotic were determined using microdilution broth assay. Escherichia coli isolates were highly resistant to ampicillin (up to 39.3%) in all regions, and existed multidrug-resistant, but zero resistance was the dominant. Escherichia coli isolates from E cattle farm in Cherqi town, Baicheng county, exhibited resistant to three kinds of quinolones (6.7%). The results suggested that the resistances of Escherichia coli isolates to commonly used antibiotics were not serious in Xinjiang.     

大连某奶牛场奶牛乳房炎病原菌分离及鉴定

本试验对大连某奶牛养殖场15头患临床型乳房炎病牛进行病原菌分离、鉴定。使用鉴别培养基对乳样中的大肠杆菌、葡萄球菌、链球菌及沙门氏菌进行分离,并对分离出的大肠杆菌进行血清学“O”抗原检测试验。结果显示,25个乳区的乳样共分离到病原菌37株,其中大肠杆菌15株、链球菌13株、葡萄球菌8株、沙门氏菌1株,乳房炎阳性率为5.2%,乳区阳性率为2.2%;大肠杆菌分离株以O51、O148、O78、O60血清型为主。     

Escherichia coli challenge and one type of smectite alter intestinal barrier of pigs

An experiment was conducted to determine how an E. coil challenge and dietary clays affect the intestinal barrier of pigs. Two groups of 32 pigs （initial BW： 6.9 ± 1.0 kg） were distributed in a 2 x 4 factorial arrangement of a randomized complete block design （2 challenge treatments： sham or E. coil, and 4 dietary treatments： control, 0.3% smectite A, 0.3% smectite B and 0.3% zeolite）, with 8 replicates total. Diarrhea score, growth performance, goblet cell size and number, bacterial translocation from intestinal lumen to lymph nodes, intestinal morphology, and relative amounts of sulfo and sialo mucins were measured. The E. coli challenge reduced performance, increased goblet cell size and number in the ileum, increased bacterial translocation from the intestinal lumen to the lymph nodes, and increased ileal crypt depth. One of the clays （smectite A） tended to increase goblet cell size in ileum, which may indicate enhanced protection. In conclusion, E. coli infection degrades intestinal barrier integrity but smectite A may enhance it.     

Changes in various metabolic parameters in blood and milk during experimental Escherichia coli mastitis for primiparous Holstein dairy cows during early lactation

Background

The objective of this study was to characterize the changes in various metabolic parameters in blood and milk during IMI challenge with Escherichia coli (E. coli) for dairy cows during early lactation. Thirty, healthy primiparous Holstein cows were infused (h = 0) with ~20-40 cfu of live E. coli into one front mammary quarter at ~4-6 wk in lactation. Daily feed intake and milk yield were recorded. At –12, 0, 3, 6, 12, 18, 24, 36, 48, 60, 72, 96, 108, 120, 132, 144, 156, 168, 180 and 192 h relative to challenge rectal temperatures were recorded and quarter foremilk was collected for analysis of shedding of E. coli. Composite milk samples were collected at -180, -132, -84, -36, -12, 12, 24, 36, 48, 60, 72, 84, 96, 132 and 180 h relative to challenge (h = 0) and analyzed for lactate dehydrogenase (LDH), somatic cell count, fat, protein, lactose, citrate, beta-hydroxybutyrate (BHBA), free glucose (fglu), and glucose-6-phosphate (G6P). Blood was collected at -12, 0, 3, 6, 12, 18, 24, 36, 60, 72, 84, 132 and 180 h relative to challenge and analyzed for plasma non-esterified fatty acids (NEFA), BHBA and glucose concentration. A generalized linear mixed model was used to determine the effect of IMI challenge on metabolic responses of cows during early lactation.

Results

By 12 h, E. coli was recovered from challenged quarters and shedding continued through 72 h. Rectal temperature peaked by 12 h post-challenge and returned to pre-challenge values by 36 h post-IMI challenge. Daily feed intake and milk yield decreased (P <0.05) by 1 and 2 d, respectively, after mastitis challenge. Plasma BHBA decreased (12 h; P <0.05) from 0.96 ± 1.1 at 0 h to 0.57 ± 0.64 mmol/L by 18 h whereas concentration of plasma NEFA (18 h) and glucose (24 h) were significantly greater, 11 and 27%, respectively, after challenge. In milk, fglu, lactose, citrate, fat and protein yield were lower whereas yield of BHBA and G6P were higher after challenge when compared to pre-challenge values.

Conclusions

Changes in metabolites in blood and milk were most likely associated with drops in feed intake and milk yield. However, the early rise in plasma NEFA may also signify enhanced adipose tissue lipolysis. Lower concentrations of plasma BHBA may be attributed to an increase transfer into milk after IMI. Decreases in both milk lactose yield and % after challenge may be partly attributed to reduced conversion of fglu to lactose. Rises in G6P yield and concentration in milk after challenge (24 h) may signify increased conversion of fglu to G6P. Results identify changes in various metabolic parameters in blood and milk after IMI challenge with E. coli in dairy cows that may partly explain the partitioning of nutrients and changes in milk components after IMI for cows during early lactation.     

Multiple‐Aetiology Enteric Infections Involving Non‐O157 Shiga Toxin‐Producing Escherichia coli – FoodNet, 2001–2010

We describe multiple‐aetiology infections involving non‐O157 Shiga toxin‐producing Escherichia coli (STEC) identified through laboratory‐based surveillance in nine FoodNet sites from 2001 to 2010. A multiple‐aetiology infection (MEI) was defined as isolation of non‐O157 STEC and laboratory evidence of any of the other nine pathogens under surveillance or isolation of >1 non‐O157 STEC serogroup from the same person within a 7‐day period. We compared exposures of patients with MEI during 2001–2010 with those of patients with single‐aetiology non‐O157 STEC infections (SEI) during 2008–2009 and with those of the FoodNet population from a survey conducted during 2006–2007. In total, 1870 non‐O157 STEC infections were reported; 68 (3.6%) were MEI; 60 included pathogens other than non‐O157 STEC; and eight involved >1 serogroup of non‐O157 STEC. Of the 68 MEI, 21 (31%) were part of six outbreaks. STEC O111 was isolated in 44% of all MEI. Of patients with MEI, 50% had contact with farm animals compared with 29% (P < 0.01) of persons with SEI; this difference was driven by infections involving STEC O111. More patients with non‐outbreak‐associated MEI reported drinking well water (62%) than respondents in a population survey (19%) (P < 0.01). Drinking well water and having contact with animals may be important exposures for MEI, especially those involving STEC O111.     

Occurrence,Virulence Genes and Antibiotic Resistance of Enteropathogenic Escherichia coli (EPEC) from Twelve Bovine Farms in the North‐East of Ireland

Cattle faecal samples (n = 480) were collected from a cluster of 12 farms, and PCR screened for the presence of the intimin gene (eae). Positive samples were cultured, and colonies were examined for the presence of eae and verocytotoxin (vtx) genes. Colonies which were positive for the intimin gene and negative for the verocytotoxin genes were further screened using PCR for a range of virulence factors including bfpA, espA, espB, tir ehxA, toxB, etpD, katP, saa, iha, lpfA_{O157/OI‐141} and lpfA_{O157/OI‐154.} Of the 480 faecal samples, 5.8% (28/480) were PCR positive, and one isolate was obtained from each. All 28 isolates obtained were bfpA negative and therefore atypical EPEC (aEPEC). The serotypes detected included O2:H27, O8:H36, O15:H2, O49:H+, O84:H28, O105:H7 and O132:H34 but half of the isolates could not be serogrouped using currently available antisera. Twenty‐two (79%) of the isolates carried the tir gene but only 25% were espB positive, and all other virulence genes tested for were scarce or absent. Several isolates showed intermediate resistance to ciprofloxacin, kanamycin, nalidixic acid, minocycline and tetracycline; full resistance to nalidixic acid or tetracycline with one isolate (O?:H8) displaying resistance to aminoglycosides (kanamycin and streptomycin), quinolones (nalidixic acid) and sulphonamides. This study provides further evidence that cattle are a potential source of aEPEC and add to the very limited data currently available on virulence genes and antibiotic resistance in this pathogenic E. coli group in animals.     

输卵管炎种鸭大肠杆菌的分离鉴定及生物学特性分析

为分析表现输卵管炎种鸭体内分离的大肠杆菌的致病性、药敏试验、血清型及毒力基因携带情况,无菌采集表现输卵管炎的种鸭肝脏,进行大肠杆菌的分离鉴定,经易感鸭皮下注射,测定其致病性;纸片法进行药敏试验;凝集试验确定血清型;PCR法检测毒力基因.结果共分离鉴定大肠杆菌16株,其中强毒菌株11株.70％以上菌株表现敏感的药物有丁胺卡那霉素、氟苯尼考、头孢唑啉、左氧氟沙星和壮观霉素,70％以上菌株表现耐受的药物有复方新诺明、卡那霉素、庆大霉素、恩诺沙星和氟哌酸.16株大肠杆菌分属于4个血清型,078占56.3％,为主要血清型.毒力基因irp2、yuA、imC和pa pC的检出率分别为68.8％、87.5％、75％和100％.总结说明,从表现输卵管炎的种鸭体内共分离到16株大肠杆菌,078是主要的血清型,首选壮观霉素和氟苯尼考等敏感药物进行治疗.